FANCONI CANCER FOUNDATION

FANCONI CANCER FOUNDATION is sponsored by FANCONI CANCER FOUNDATION. Supports research and provides resources for individuals affected by Fanconi anemia and associated cancers.

RFA: ACS - Fanconi Cancer Foundation Discovery Boost Grant | American Cancer Society https://searchapi. cancer. org Use double-quotes ("") around a phrase for an exact result Our 24/7 cancer helpline provides information and answers for people dealing with cancer.

We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear. Live Chat available weekdays, 7:00 am - 6:30 pm CT Call us at 1-800-227-2345 Available any time of day or night Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat.

We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include: Referrals to patient-related programs or resources Donations, website, or event-related assistance For medical questions, we encourage you to review our information with your doctor.

Research We Fund: Extramural Discovery Science (EDS) Apply for a Research Grant Arizona (AZ) Discovery Boost Grants (DBG) ASTRO-ACS Clinician Scientist Development Grant (CSDG) Clinician Scientist Development Grant (CSDG) Discovery Boost Grants (DBG) HEALED Gold Medal RFA To Support Mind-Body-Spirit Wellness in Cancer Survivors Institutional Research Grants Mission Boost Grants (MBG) RFA: Extramural Discovery Science Accelerator Award RFA: Leukemia Exploration and Prevention Grant Program (LEAP) TheoryLab Collaborative (TLC) Grant RFA: Cancer Health Research Centers (CHERCs) RFA: Biology to Prevention Award (CRUK) RFA: ACS - Fanconi Cancer Foundation Discovery Boost Grant RFA: American Cancer Society Catalyst Awards RFA: American Cancer Society - Flatiron Real-World Data Impact Award RFA: Yosemite-American Cancer Society Award Extramural Grants Department Staff Contacts Definition of Research Areas FAQs: ACS Extramural Discovery Science and Grant Application Submissions Extramural Priority Research Areas Summer 2026 Grant Cycle: Summary of Changes American Cancer Society Research Events EDS: Our Research Programs Career Growth and Research Excellence Program Cancer Detection and Experimental Therapeutics (PF-CDET) Institutional Research Grants (IRG) Cell Biology and Immunology (PF-CBI) Clinical and Population Sciences (PF-CPS) Molecular Biology and Biochemistry (PF-MBB) Biochemistry and Immunology of Cancer Program DNA Mechanisms in Cancer (DMC) PRC Immunology and Blood Cell Development (IBCD) PRC RNA Mechanisms in Cancer (RMC) PRC Tumor Biochemistry and Endocrinology (TBE) PRC Mission Boost Grants (MBG) PRC Cell Biology and Preclinical Cancer Research Program Cancer Cell Biology (CCB) PRC Cancer Detection and Progression (CDP) PRC Experimental Therapeutics (ET) PRC Metastasis and Microenvironment (MM) PRC Clinical and Population Sciences Program Cancer Prevention and Health Promotion (CPHP) PRC Treatment, Palliative Care, and Survivorship Research (CTPS) Etiology, Screening, and Early Detection (ESED) Healthcare Outcomes, Policy, and Systems Research (HOPS) Peer Review Committees (PRCs) Discovery Scientific Council Community Research Partner Participation American Cancer Society Professors Nobel Laureates and the American Cancer Society American Cancer Society-Jiler Professors & Fellows Conference RFA: ACS - Fanconi Cancer Foundation Discovery Boost Grant The American Cancer Society (ACS) and the Fanconi Cancer Foundation (FCF) have partnered to invite proposals for translational cancer research projects that address the unique challenges faced by individuals with Fanconi anemia (FA).

FA is a rare inherited disorder caused by mutations in genes critical for DNA repair, including BRCA1 and BRCA2. This award will support high-risk, high-reward projects with transformative potential—innovative ideas that push the boundaries of current understanding and hold promise for meaningful clinical application.

We aim to fund bold translational research that can lead to improved detection, prevention, or treatment of cancers in individuals with FA. Application Deadline: Dec. 1, 2025 Application Review Period: Feb.

- Mar. 2026 Anticipated Notification of Award: Aug. 2026 Anticipated Grant Start Date: Oct.

1, 2026 Research must be translational in nature and directly applicable to FA-associated cancers, particularly those influenced by defects in the FA/BRCA DNA repair pathway in people with FA. The proposed project should clearly state how it will advance FA cancer research and lead to clinical benefit for individuals with FA.

Applications may come from FA experts or researchers in related cancer biology fields who propose pivoting toward FA-relevant studies. Applications from investigators new to the FA research field should show strong relevance and impact toward the below areas of interest.

Areas of interest include, but are not limited to: Early detection technologies and biomarkers for FA-related squamous cell carcinomas Mechanisms or interventions to prevent FA-related tumors Therapeutic strategies tailored to the FA population’s sensitivity to DNA-damaging agents Novel models to study FA tumorigenesis and treatment response High-throughput or systems biology approaches to identify FA-specific cancer vulnerabilities Preference will be given to proposals with a clear translational path for detecting, preventing, or treating cancer in people with FA, including collaborations with clinicians, diagnostic developers, or pharmaceutical partners.

Typically, you are eligible to submit a proposal if you: Work at a US academic institution or eligible non-profit Are an independent investigator at any career stage with a full-time faculty appointment (or equivalent) Applicants are encouraged to review the eligibility criteria in the grant policies document. Awards are for up to $135,000 direct costs per year for up to 2 years, plus 10% indirect costs.

The maximum allowable budget is $297,000 for a 2-year project period. Program Contact: Doug Hurst, PhD, at doug. hurst@cancer.

org Link to Policies Link to Instructions The Fanconi Cancer Foundation (FCF) is the leading global nonprofit dedicated to advancing research, advocacy, and support for people affected by Fanconi anemia (FA) and associated cancers. FCF has funded over $32 million in research worldwide, driving advances in bone marrow transplant, gene therapy, and cancer prevention.

Current initiatives include a FA data commons, global research consortia, and a repository of shared research materials. FCF fosters scientific collaboration, community empowerment, and clinical innovation to improve and extend the lives of individuals with FA. Help us end cancer as we know it, for everyone.